Dr. Theocharides is one of only 10 physicians around the country chosen to participate in the ThermiVa Laxity Study. Participants will benefit from discounted treatment costs and the satisfaction of both personal results and the knowledge gained through the study on the range of physical concerns that can be addressed with this treatment.
ThermiVa uses radio frequency (RF) generated heat to shrink targeted tissue of the vagina and vaginal canal, addressing vaginal looseness and labial sagging that could be the result of childbirth, aging, obesity or repeated heavy lifting. The treatment is quick, painless and requires no down time- you can resume normal activities right away.
Laxity Study: Participant Criteria
There are a few basic criteria that all participants must meet to be eligible for consideration:
- Must be between the ages of 21 and 65
- Sexually active (defined as once per month or more)
- Healthy and absent of active STDs
- Not pregnant or planning to become pregnant during duration of treatment
- No IUD in place
- Experiencing vaginal looseness
ThermiVa was developed by ThermiGyn to treat vulvovaginal laxity and associated side effects such as minimized sexual pleasure and labial sagging. This revolutionary procedure has also been shown to be effective in treating mild stress incontinence, vaginal dryness and sexual dysfunction that has resulted from decreased sensitivity.
The results of this national study will lay the foundation for treatment protocol and future applications for ThermiVa in helping women enjoy a happier, healthier life! If you are interested in being a participant in the Laxity Study, contact Nadine at 732-508-7778 to begin the application process and learn more about this revolutionary treatment.